# US 2019/0153522 A1 · Molecular Detection Using Ligation Amplification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0153522 A1
- Document ID: US20190153522A1
- Status: Published application
- Kind: A1
- Application number: 16/254,926
- Filed: 2019-01-23
- Published: 2019-05-23
- Earliest claimed: 2016-12-16
- Assignees: Aratome, LLC
- Applicants: Aratome, LLC
- Inventors: Jay TRAUTMAN; Gordon WANG; David LENZI
- Web page: https://patentgrep.com/patent/US20190153522A1

## CPC

- C12Q 1/6827: for detection of mutation or polymorphism
- C07K 16/20: from protozoa
- C12Q 1/44: involving esterase
- C12Q 1/68: involving nucleic acids
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C12Q 1/682: Signal amplification
- C12Q 1/6823: Release of bound markers
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12Q 1/6888: for detection or identification of organisms
- G01N 1/36: Embedding or analogous mounting of samples
- G01N 33/532: Production of labelled immunochemicals
- G01N 33/533: with fluorescent label
- G01N 33/582: {with fluorescent label}
- G01N 33/585: {with a particulate label, e.g. coloured latex}
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 2563/107: fluorescence
- C12Y 605/01001: DNA ligase (ATP) (6.5.1.1)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Y: ENZYMES

## Abstract

Disclosed herein are compositions, kits, methods, and systems for detecting a target molecule in a sample using a detection molecule.

## Claims

### Claim at position 1

1-177. (canceled)

### Claim 178

A composition that comprises:
a detection molecule and an antisense oligomer,
wherein the detection molecule comprises: i) a ligand that binds a target molecule in a sample; and ii) a single-stranded nucleic acid linked to the ligand, and
wherein the single-stranded nucleic acid is capable of hybridizing to the antisense oligomer to form a double-stranded nucleic acid label that has an overhang comprising one or more unpaired nucleotides in the single-stranded nucleic acid or the anti sense oligomer.

### Claim 179 (depends on 178)

The composition of claim 178, wherein the ligand is an antibody, or wherein the target molecule is a protein.

### Claim 180 (depends on 178)

The composition of claim 178, wherein the overhang comprises at least: 5, 10, 15, 20, 25, or 30 nucleotides.

### Claim 181 (depends on 178)

The composition of claim 178, wherein the composition comprises a plurality of the detection molecules.

### Claim 182 (depends on 181)

The composition of claim 181, wherein each of the plurality of detection molecules binds a different target molecule.

### Claim 183 (depends on 178)

The composition of claim 178, wherein the sample is an intact tissue sample.

### Claim 184 (depends on 178)

The composition of claim 178 that further comprises a DNA ligase or a detection label.

### Claim 185 (depends on 184)

The composition of claim 184, wherein the detection label comprises a detection tag.

### Claim 186 (depends on 185)

The composition of claim 185, wherein the detection tag comprises a fluorophore that comprises coumarin, rhodamine, xanthene, fluorescein, or cyanine.

### Claim 187 (depends on 184)

The composition of claim 184, wherein the detection label is one, two, or more labels, each of which comprises an overhang that is complementary to the overhang of the double-stranded nucleic acid label.

### Claim 188 (depends on 187)

The composition of claim 187, wherein the detection label is linked to the overhang of the double-stranded nucleic acid label by direct hybridization, enzymatic ligation, or chemical ligation to form a structure.

### Claim 189 (depends on 187)

The composition of claim 187, wherein the detection label comprises a multi-way branch.

### Claim 190 (depends on 189)

The composition of claim 189, wherein the multi-way branch is a three-way branch or a four-way branch.

### Claim 191 (depends on 189)

The composition of claim 189, wherein the multi-way branch has a T-structure with 3 overhangs, or a cross structure with 4 overhangs.

### Claim 192 (depends on 189)

The composition of claim 189, wherein the multi-way branches are oligomerized by cycling or self-assembling.

### Claim 193 (depends on 192)

The composition of claim 192, wherein a number of the cycling is from 2 to 10.

### Claim 194 (depends on 192)

The composition of claim 192, wherein the oligomerizing is a linear amplification or a branched amplification.

### Claim 195 (depends on 178)

A kit that comprises the detection molecule and the antisense oligomer of claim 178.

### Claim 196 (depends on 178)

A method, comprising contacting the target molecule with the detection molecule and the antisense oligomer of claim 178.

### Claim 197

A composition that comprises:
1) a detection molecule, wherein the detection molecule comprises: i) an antibody that binds a target protein, and ii) a single-stranded nucleic acid linked to the antibody;
2) an antisense oligomer, wherein the antisense oligomer is capable of hybridizing to the single-stranded nucleic acid to form a double-stranded nucleic acid label that has an overhang comprising one or more unpaired nucleotides in the single-stranded nucleic acid or the antisense oligomer; and
3) a detection label that comprises a detection tag and an overhang, wherein the detection tag comprises a fluorophore, and wherein the overhang of the detection label is complementary to the overhang of the double-stranded nucleic acid label.
